AdaptHealth Corp. (AHCO) SEC News Jan. 13, 2026, 21:22 UTC 5 1 comments Director BELINFANTI GREGORY 🟢 acquired 11.8K shares of AdaptHealth Corp. (AHCO) Transaction Date: Jan 09, 2026 | Filing ID: 003345 Comment Full text
Warby Parker Inc (WRBY) SEC News Jan. 13, 2026, 21:21 UTC 7 1 comments 📋 NEIL BLUMENTHAL (Director) plans to sell 660 shares of Warby Parker Inc. (at $26.58 each, total $18K) Filed: Jan 13, 2026 | ID: 000380 Comment Full text
Iradimed Co (IRMD) SEC News Jan. 13, 2026, 21:20 UTC 5 1 comments Susi Roger E. 🔴 sold 5.0K shares of IRADIMED CORP (IRMD) at $98.15 Transaction Date: Jan 12, 2026 | Filing ID: 000004 Comment Full text
Shattuck Labs Inc (STTK) SEC News Jan. 13, 2026, 21:17 UTC 6 0 comments New Form S-3 - Shattuck Labs, Inc. Filed: 2026-01-13 AccNo: 0001193125-26-011760 Size: 864 KB Comment Full text
Sharps Technology Inc (STSS) SEC News Jan. 13, 2026, 21:15 UTC 7 0 comments New Form 424B3 - Sharps Technology Inc. Filed: 2026-01-13 AccNo: 0001493152-26-002046 Size: 586 KB Comment Full text
Zymeworks Inc (ZYME) SEC News Jan. 13, 2026, 21:15 UTC 7 0 comments New Form 3 - Zymeworks Inc. Filed: 2026-01-13 AccNo: 0001193125-26-011754 Size: 14 KB Comment Full text
Bruker Corporation (BRKR) SEC News Jan. 13, 2026, 21:15 UTC 4 1 comments Munch Mark 🟡 adjusted position in 7.0K shares (1 derivative) of BRUKER CORP (BRKR) at $55.00 Transaction Date: Jan 12, 2026 | Filing ID: 000004 Comment Full text
Olema Oncology (OLMA) SEC News Jan. 13, 2026, 21:12 UTC 6 1 comments 📋 Myles David C. (Officer) plans to sell 50K shares of Olema Pharmaceuticals, Inc. (at $27.60 each, total $1.4M) Filed: Jan 13, 2026 | ID: 000286 Comment Full text
Forte Biosciences Inc. (FBRX) SEC News Jan. 13, 2026, 21:12 UTC 7 1 comments Riley Antony A 🟢 acquired 150.0K shares (2 derivative) of Forte Biosciences, Inc. (FBRX) at $29.66 ($2.7M) Transaction Date: Jan 12, 2026 | Filing ID: 000004 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 21:12 UTC 7 1 comments 📋 Nicholson Nur (Officer) plans to sell 3K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $58K) Filed: Jan 13, 2026 | ID: 000285 Comment Full text